'Party pill' drugs--BZP and TFMPP

Area of Science:

• Pharmacology
• Toxicology
• Drug Metabolism

Background:

• Benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) are common components of recreational 'party pills'.
• These drugs are structurally similar to amphetamines and exert effects via interactions with dopamine (DA) and serotonin (5-HT) receptors.
• Previous research indicates potential pharmacodynamic drug-drug interactions between BZP and TFMPP.

Purpose of the Study:

• To investigate the pharmacokinetic properties of BZP and TFMPP when administered alone and in combination.
• To elucidate the metabolic pathways of BZP and TFMPP, focusing on their interactions with hepatic cytochrome P450 (CYP450) enzymes.
• To assess the potential for BZP and TFMPP to cause drug-drug interactions through metabolic inhibition.

Main Methods:

• Pharmacokinetic studies analyzing BZP and TFMPP concentrations in biological samples.
• In vitro assays using human liver microsomes to identify involved CYP450 enzymes (CYP2D6, CYP1A2, CYP3A4).
• Assessment of metabolic inhibition potential of BZP and TFMPP on substrates of key CYP450 enzymes.

Main Results:

• BZP and TFMPP undergo metabolism primarily mediated by CYP2D6, CYP1A2, and CYP3A4.
• Co-administration of BZP and TFMPP alters their individual pharmacokinetic profiles.
• Evidence of BZP and TFMPP inhibiting the metabolism of other drugs processed by these CYP450 enzymes, particularly notable in poor CYP2D6 metabolisers.

Conclusions:

• BZP and TFMPP exhibit significant drug-drug interaction potential due to their metabolism via major CYP450 enzymes.
• Individuals with genetic variations affecting CYP2D6 activity may experience altered drug responses when using BZP and TFMPP.
• Understanding these interactions is crucial for clinical toxicology and harm reduction strategies related to recreational drug use.